Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Puppy successfully treated for vitamin D poisoning
Miniature dachshund Margot arrived at the hospital with depression, lethargy and nausea.

Miniature dachshund Margot is recovering after devouring human psoriasis medication.

A puppy has been treated successfully for vitamin D poisoning after eating a human medicine containing a synthetic form of the supplement. 

Miniature dachshund Margot was presented to Davies Veterinary Specialists after gobbling up a tube of Dovonex ointment - a topical cream used to treat psoriasis in humans that contains
calcipotriol, a synthetic derivative of vitamin D.

“We calculated that four-month-old Margot had ingested between 500-1000µg (161µg/kg – 323µg/kg) of calcipotriol,” explained Katherine Clarke, an internal medicine resident at Davies. “Toxicity studies in dogs suggest that 1.8 to 3.6µg /kg /day of calcipotriol can cause disturbances in calcium homeostasis, so it wasn’t surprising that Margot developed evidence of toxicity.” 

Margot arrived at the veterinary hospital with depression, lethargy and nausea. She was also severely hypercalcaemic and mildly azotaemic.

The team initially managed her vitamin D poisoning with prednisolone, furosemide and intravenous fluid therapy. While she did show some clinical improvement, the hypercalcaemia persisted, prompting the addition of pamidronate to her treatment. 

The combination of the treatments resulted in normocalcaemia and resolution of the azotaemia. The furosemide was then stopped, and the intravenous fluid therapy was gradually reduced over a few days; her calcium remained normal. 

Margot was discharged on tapering doses of prednisolone and blood tests were performed before each dose reduction to ensure she remained normocalcaemic. She is now said to be be clinically very well having been off all treatment for a few months, and there are no signs that the vitamin D poisoning has led to any permanent damage. 

“Vitamin D toxicity is relatively rare, although the growing trend in vitamin D supplementation in the human population means that dogs are more likely to have access to this vitamin,” said Katherine. 

“Ingestion of psoriasis cream, either by licking it from the skin of the owner or direct ingestion by chewing the tube, is another well-recognised mechanism of vitamin D toxicity in dogs,” she continued. “The addition of vitamin D (cholecalciferol) to rodenticides is also increasing, ingestion of which would cause the undesirable combination of vitamin D toxicosis and a coagulopathy”.

“The prognosis for vitamin D toxicity is variable with some cases experiencing an acute kidney injury or severe gastrointestinal bleeding due to calcification of the soft tissues. However, with prompt, aggressive treatment the prognosis can be reasonable.”

 

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.